FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:867-869 March 14, 2002 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Vancomycin-resistant enterococci have become important nosocomial pathogens in the United States. Since November 1995, rectal swabs for surveillance for vancomycin-resistant enterococci have been collected twice weekly from adult patients admitted to the liver, kidney, and pancreas transplantation unit at our institution.¹ Recently, linezolid-resistant, vancomycin-resistant Enterococcus faecium was isolated from seven patients at our institution. All isolates carried the vanA gene and were resistant to linezolid (minimal inhibitory concentration [MIC], 16 µg per milliliter), ampicillin, penicillin, gentamicin, streptomycin, and vancomycin and were susceptible to quinupristin–dalfopristin and the investigational agents oritavancin (MIC, 1 µg per milliliter) and tigecycline (MIC, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Schmidt, S., Sabarinath, S. N., Barbour, A., Abbanat, D., Manitpisitkul, P., Sha, S., Derendorf, H. (2009). Pharmacokinetic-Pharmacodynamic Modeling of the In Vitro Activities of Oxazolidinone Antimicrobial Agents against Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 5039-5045 [Abstract] [Full Text]  
• Mave, V., Garcia-Diaz, J., Islam, T., Hasbun, R. (2009). Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?. J Antimicrob Chemother 64: 175-180 [Abstract] [Full Text]  
• Ge, Y., Biek, D., Talbot, G. H., Sahm, D. F. (2008). In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States. Antimicrob. Agents Chemother. 52: 3398-3407 [Abstract] [Full Text]  
• Scheetz, M. H., Knechtel, S. A., Malczynski, M., Postelnick, M. J., Qi, C. (2008). Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption. Antimicrob. Agents Chemother. 52: 2256-2259 [Abstract] [Full Text]  
• Lawrence, L., Danese, P., DeVito, J., Franceschi, F., Sutcliffe, J. (2008). In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens. Antimicrob. Agents Chemother. 52: 1653-1662 [Abstract] [Full Text]  
• Kelly, S., Collins, J., Maguire, M., Gowing, C., Flanagan, M., Donnelly, M., Murphy, P. G. (2008). An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother 61: 901-907 [Abstract] [Full Text]  
• Fishman, J. A. (2007). Infection in Solid-Organ Transplant Recipients. NEJM 357: 2601-2614 [Full Text]  
• Eiland, E. H. III, Robinson, J. B. (2007). Effect of linezolid on the occurrence of vancomycin-resistant enterococci. Am J Health Syst Pharm 64: 2535-2536 [Full Text]  
• Souli, M., Kontopidou, F. V., Koratzanis, E., Antoniadou, A., Giannitsioti, E., Evangelopoulou, P., Kannavaki, S., Giamarellou, H. (2006). In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals.. Antimicrob. Agents Chemother. 50: 3166-3169 [Abstract] [Full Text]  
• Dobbs, T. E., Patel, M., Waites, K. B., Moser, S. A., Stamm, A. M., Hoesley, C. J. (2006). Nosocomial Spread of Enterococcus faecium Resistant to Vancomycin and Linezolid in a Tertiary Care Medical Center.. J. Clin. Microbiol. 44: 3368-3370 [Abstract] [Full Text]  
• Zirakzadeh, A., Patel, R. (2006). Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment. Mayo Clin Proc. 81: 529-536 [Abstract] [Full Text]  
• Bonora, M. G., Solbiati, M., Stepan, E., Zorzi, A., Luzzani, A., Catania, M. R., Fontana, R. (2006). Emergence of Linezolid Resistance in the Vancomycin-Resistant Enterococcus faecium Multilocus Sequence Typing C1 Epidemic Lineage.. J. Clin. Microbiol. 44: 1153-1155 [Abstract] [Full Text]  
• Jones, R. N., Ross, J. E., Fritsche, T. R., Sader, H. S. (2006). Oxazolidinone susceptibility patterns in 2004: report from the Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother 57: 279-287 [Abstract] [Full Text]  
• Draghi, D. C., Sheehan, D. J., Hogan, P., Sahm, D. F. (2005). In Vitro Activity of Linezolid against Key Gram-Positive Organisms Isolated in the United States: Results of the LEADER 2004 Surveillance Program. Antimicrob. Agents Chemother. 49: 5024-5032 [Abstract] [Full Text]  
• Yoon, E. J., Jo, Y. W., Choi, S. H., Lee, T. H., Rhee, J. K., Yoo, M., Shim, M. J., Choi, E. C. (2005). In Vitro and In Vivo Activities of DA-7867, a New Oxazolidinone, against Aerobic Gram-Positive Bacteria. Antimicrob. Agents Chemother. 49: 2498-2500 [Abstract] [Full Text]  
• Liao, C.-H., Tseng, S.-P., Fang, C.-T., Teng, L.-J., Hsueh, P.-R. (2005). First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan. J Antimicrob Chemother 55: 598-599 [Full Text]  
• Werner, G., Strommenger, B., Klare, I., Witte, W. (2004). Molecular Detection of Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis by Use of 5' Nuclease Real-Time PCR Compared to a Modified Classical Approach. J. Clin. Microbiol. 42: 5327-5331 [Abstract] [Full Text]  
• Dibo, I., Pillai, S. K., Gold, H. S., Baer, M. R., Wetzler, M., Slack, J. L., Hazamy, P. A., Ball, D., Hsiao, C. B., McCarthy, P. L. Jr., Segal, B. H. (2004). Linezolid-Resistant Enterococcus faecalis Isolated from a Cord Blood Transplant Recipient. J. Clin. Microbiol. 42: 1843-1845 [Abstract] [Full Text]  
• Mutnick, A. H, Enne, V., Jones, R. N (2003). Linezolid Resistance Since 2001: SENTRY Antimicrobial Surveillance Program. The Annals of Pharmacotherapy 37: 769-774 [Abstract] [Full Text]  
• Lomaestro, B. M (2003). Resistance to Linezolid. Are We Surprised? How Hard Should We Look?. The Annals of Pharmacotherapy 37: 909-911 [Full Text]  
• Critchley, I. A., Draghi, D. C., Sahm, D. F., Thornsberry, C., Jones, M. E., Karlowsky, J. A. (2003). Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. J Antimicrob Chemother 51: 639-649 [Abstract] [Full Text]  
• Auckland, C., Teare, L., Cooke, F., Kaufmann, M. E., Warner, M., Jones, G., Bamford, K., Ayles, H., Johnson, A. P. (2002). Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother 50: 743-746 [Abstract] [Full Text]